We are live on ! Find out more
AIM

Allen Investment Management Portfolio holdings

AUM $8.43B
1-Year Est. Return 20.31%
This Fund
S&P 500
This Quarter Est. Return
+7.54%
1 Year Est. Return
+20.31%
3 Year Est. Return
+92.36%
5 Year Est. Return
+101.99%
10 Year Est. Return
+554.07%
AUM
$1.37B
AUM Growth
+$41.5M
Cap. Flow
-$9.05M
Cap. Flow %
-0.66%
Top 10 Hldgs %
33.23%
Holding
258
New
33
Increased
62
Reduced
69
Closed
29

Top Buys

Rank Stock Value
1
SLXP
SALIX PHARMACEUTICALS LTD DEL
SLXP
+$44M
2
DTV
DIRECTV COM STK (DE)
DTV
+$32.4M
3
DHR icon
Danaher
DHR
+$25.8M
4
ACWX icon
iShares MSCI ACWI ex US ETF
ACWX
+$20.5M
5
PCYC
PHARMACYCLICS INC
PCYC
+$19.3M

Top Sells

Rank Stock Value
1
AGN
Allergan Inc
AGN
+$86.9M
2
CBST
CUBIST PHARMACEUTICALS INC
CBST
+$61.4M
3
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
+$45M
4
TLM
TALISMAN ENERGY INC
TLM
+$19.6M
5
SXC icon
SunCoke Energy
SXC
+$16.3M

Sector Composition

Rank Sector Weight
1 Healthcare 21.45%
2 Technology 16.55%
3 Industrials 7.98%
4 Consumer Discretionary 7.23%
5 Financials 7.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TRW
251
DELISTED
TRW AUTOMOTIVE HOLDINGS CORP
TRW
– –
-5,263
Closed -$541K
TLM
252
DELISTED
TALISMAN ENERGY INC
TLM
– –
-2,500,000
Closed -$19.6M
PETM
253
DELISTED
PETSMART INC
PETM
– –
-8,810
Closed -$716K
SWY
254
DELISTED
SAFEWAY INC
SWY
– –
-15,209
Closed -$534K
AUXL
255
DELISTED
AUXILIUM PHARAMCEUTICALS INC
AUXL
– –
-11,570
Closed -$398K
CBST
256
DELISTED
CUBIST PHARMACEUTICALS INC
CBST
– –
-610,276
Closed -$61.4M
COV
257
DELISTED
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
– –
-440,000
Closed -$45M
AGN
258
DELISTED
Allergan Inc
AGN
– –
-408,601
Closed -$86.9M
7 8 9 10
11

Similar funds

FT
Fiduciary Trust Boston, Massachusetts $8.46B AUM 21.38% 1-Year Est. Return
AAF
Andra AP-fonden Goteborg, Sweden $8.39B AUM 21.19% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
GRQ
Gardner Russo & Quinn Lancaster, Pennsylvania $8.5B AUM 9.79% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return
IC
Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return
NB
Norinchukin Bank Tokyo, Japan $8.57B AUM 20.17% 1-Year Est. Return

Allen Investment Management's Q1 2015 Portfolio in Review

As of Q1 2015, Allen Investment Management held 258 positions worth $1.37B, up 3.1% from $1.32B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Allen Investment Management's Q1 2015 filing shows 33 new, 62 increased, 69 reduced and 29 closed positions. Its largest new stake was SALIX PHARMACEUTICALS LTD DEL: 300,000 shares worth $51.8M. The largest sale was Allergan Inc, an estimated $86.9M.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, down from 29% a quarter earlier, followed by Technology and Industrials.

  • Allen Investment Management's largest Q1 2015 buy was SALIX PHARMACEUTICALS LTD DEL: 300,000 shares worth $51.8M.
  • Allen Investment Management added most to DIRECTV COM STK (DE) in Q1 2015, an estimated $32.4M increase.
  • Allen Investment Management's biggest Q1 2015 reduction was Molson Coors Class B, cutting an estimated $16M.
  • Allen Investment Management fully exited Allergan Inc in Q1 2015, selling an estimated $86.9M.
  • Allen Investment Management's ten largest holdings make up 33% of its $1.37B portfolio in Q1 2015.
  • Allen Investment Management opened 33 new positions and closed 29 in Q1 2015.
  • Allen Investment Management's portfolio value rose 3.1% quarter-over-quarter to $1.37B.

Based on Allen Investment Management's 13F filing for Q1 2015, filed 15 May 2015.